Jscreenorg Inc

“A copy of the 990 was provided to the board for review and approval prior to filing.”

“An interested person annually discloses the existence of her, his or their private interest in, and the material facts relating to, a proposed transaction or arrangement. After disclosure of the private interest and all material facts, and after any discussion with the interested person, the interested person leaves the board or committee meeting while the determination of a conflict of interest is discussed and voted upon. The remaining board or committee members decides if a conflict of interest exists or could reasonably be construed to exist. The interested person is forbidden from influencing or attempting to influence the discussion of, or the vote on, whether the transaction or arrangement gives rise to a possible conflict of interest. If the board or committee has reasonable cause to believe that an interested person has failed to disclose an actual or possible conflict of interest, it informs the interested person of the basis for such belief and affords the interested person an opportunity to explain the alleged failure to disclose. If, after hearing the response of the interested person and making such further investigation as may be warranted under the circumstances, the board or committee determines that the interested person has, in fact, failed to disclose an actual or possible conflict of interest, it may, at its discretion, take (or, in the case of a committee lacking such authority, may recommend that the board take): (i) appropriate corrective action including ratifying or nullifying the transaction or arrangement; (ii) appropriate disciplinary action, if any, against the interested person, up to and including termination; and (iii) any other action the board reasonably deems to be in the best interest of the corporation.”

“The ceo's compensation was determined prior to spinout from emory using their process and comparable data, including feedback from donors, prior to hire. Compensation of other officers and key employees was reviewed by the board of directors following spinout from emory using the directors' industry experience and comparable data during the december board meeting (and reflected in the minutes of that meeting). The last compensation review took place in december 2024.”

“The organization makes its governing documents, conflict of interest policy and financial statements available upon request.”

“Michelle zimmerman was compensated for services provided to the organization, and not in her capacity as board director.”

“Lab fees: program service expenses 41,746. Management and general expenses 0. Fundraising expenses 0. Total expenses 41,746. Dna platform fees: program service expenses 53,607. Management and general expenses 0. Fundraising expenses 0. Total expenses 53,607. Consulting: program service expenses 2,117. Management and general expenses 21,342. Fundraising expenses 1,369. Total expenses 24,828.”